SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 149 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $767,746 | -49.8% | 33,207 | -43.0% | 0.00% | -50.0% |
| Q2 2023 | $1,528,285 | -7.2% | 58,287 | -8.9% | 0.00% | -20.0% |
| Q1 2023 | $1,647,231 | +5.7% | 63,995 | +6.9% | 0.01% | 0.0% |
| Q4 2022 | $1,557,791 | +1.4% | 59,892 | +11.2% | 0.01% | 0.0% |
| Q3 2022 | $1,537,000 | +174.5% | 53,874 | +137.0% | 0.01% | +400.0% |
| Q2 2022 | $560,000 | -74.6% | 22,734 | -41.9% | 0.00% | -80.0% |
| Q1 2022 | $2,207,000 | -8.9% | 39,100 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,423,000 | +1.0% | 39,100 | +3.4% | 0.01% | 0.0% |
| Q3 2021 | $2,398,000 | -23.0% | 37,800 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $3,115,000 | +30.7% | 37,800 | +16.7% | 0.01% | +20.0% |
| Q1 2021 | $2,384,000 | -1.6% | 32,400 | -3.0% | 0.01% | -16.7% |
| Q4 2020 | $2,422,000 | +50.3% | 33,400 | -1.2% | 0.01% | +50.0% |
| Q3 2020 | $1,611,000 | +13.5% | 33,800 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,420,000 | +226.4% | 33,800 | +109.9% | 0.00% | +300.0% |
| Q1 2020 | $435,000 | – | 16,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |